Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 582, pseudogene (RN7SL582P)

Target
RN7SL582P
Molecular classification
Pseudogene, Non-coding RNA (derived from 7SL RNA), Retrotransposed element
01

Overview

RN7SL582P is a processed human pseudogene derived from 7SL RNA, the RNA component of the signal recognition particle (SRP). The SRP is critical for co-translational targeting of nascent proteins to the endoplasmic reticulum[1][3]. RN7SL pseudogenes, including RN7SL582P, arise through genetic reverse flow events and are dispersed throughout the genome. These pseudogenes are truncated and not normally transcribed at functional levels nor do they contribute actively to cellular processes. Their sequences may reflect evolutionary remnants of the SRP pathway, but are not known to participate in any active biological or pathological processes[5]. The canonical 7SL RNA gene itself plays architectural and regulatory roles in SRP assembly, translation arrest, and protein translocation[1], but RN7SL582P does not encode these functions.

Other names
RN7SL582PRNA, 7SL, cytoplasmic 582, pseudogene
02

Mechanism of action

None; as a pseudogene, it does not possess a targetable biological activity[5]

03

Biological functions

No known biological function as a pseudogene itselfParent 7SL RNA is involved in SRP-mediated protein targeting[1][3]Some pseudogene transcripts can act as miRNA sponges or interfere with parental gene regulation, but specific function for RN7SL582P is not established[2]
04

Disease associations

None directly attributed; pseudogenes have been implicated in gene regulation and potentially serve as biomarkers in cancer or epigenetic regulation, but not RN7SL582P specifically[2]
05

Safety considerations

None; pseudogenes are not typically associated with safety risks for therapeutic development
06

Interacting drugs

None known; no drugs are reported to interact with RN7SL582P[5]
07

Biomarkers

None known for this specific pseudogene[4]

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 582, pseudogene (RN7SL582P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 582, pseudogene (RN7SL582P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call